Arthrogryposis Global Market Report 2025

The arthrogryposis market size has grown strongly in recent years. It will grow from $0.93 billion in 2024 to $0.98 billion in 2025 at a compound annual growth rate (CAGR) of 5.8%. The growth during the historic period can be attributed to the rising prevalence of osteoarthritis, an increase in sports-related injuries, a growing aging population, more sedentary lifestyles, and heightened awareness of osteoarthritis therapeutics.

The arthrogryposis market size is expected to see strong growth in the next few years. It will grow to $1.22 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period is expected to be driven by the expanding geriatric population, a higher adoption of pain medications, an increasing number of sports injuries, the rising prevalence of osteoarthritis, and a growing population at risk for the condition. Key trends during this period include advancements in medical technology, innovations in genetic research, technological progress in treatment options, the development of non-surgical treatments, and advancements in biologics and stem cell therapies.

The increasing prevalence of congenital disorders is expected to drive the growth of the arthrogryposis market in the coming years. Congenital disorders are abnormalities that occur during fetal development, either structurally or functionally, and are present at birth. Several factors contribute to the rising prevalence of congenital disorders, including advancements in prenatal diagnostics, environmental exposures, genetic mutations, and lifestyle changes. Arthrogryposis plays a crucial role in understanding congenital disorders by emphasizing the importance of fetal movement, genetic factors, and neuromuscular development in musculoskeletal abnormalities. For example, in February 2023, the World Health Organization reported that approximately 240,000 newborns worldwide die from congenital disorders within the first 28 days of life each year. Additionally, congenital conditions lead to an estimated 170,000 child deaths between the ages of 1 month and 5 years. As a result, the increasing prevalence of congenital disorders is contributing to the growth of the arthrogryposis market.

The growing availability of telehealth services is expected to further drive the growth of the arthrogryposis market. Telehealth services use digital communication tools such as video calls, phone calls, and online messaging to provide healthcare remotely, allowing patients to receive care from home or other locations. The rise in telehealth services can be attributed to their convenience, accessibility, and potential to reduce healthcare costs while improving patient access to care, particularly in remote or underserved areas. Telehealth is beneficial for arthrogryposis patients by enabling remote consultations, early diagnosis, and ongoing management of joint contractures, improving access to specialized care for individuals with mobility challenges. For instance, in May 2024, the Australian Digital Health Agency reported that over 95,000 practitioners had utilized telehealth services, offering 118.2 million telehealth consultations to 18 million patients over the past two years. Consequently, the increasing use of telehealth services is driving the growth of the arthrogryposis market.

Companies in the arthrogryposis market are also focusing on advancing surgical techniques, such as carpal wedge osteotomy, to improve joint mobility and reduce contractures, ultimately enhancing patients' functional outcomes and quality of life. Carpal wedge osteotomy is a surgical procedure that involves removing a wedge-shaped section of bone from the wrist to correct joint deformities and improve hand function in patients with conditions such as arthrogryposis. For example, in November 2022, Akron Children's Hospital, a US-based pediatric care hospital, developed a new procedure combining carpal wedge osteotomy with flexor-pronator slide to improve joint mobility in patients with this rare condition, which is characterized by stiff or contracted joints.

Major players in the arthrogryposis market are Hitachi Ltd., The Cleveland Clinic Foundation, The Johns Hopkins Health System Corporation, NYU Langone Hospitals, Seattle Children's Hospital, Boston Children's Hospital, Phoenix Children's Hospital Inc., Children's Healthcare of Atlanta Inc., The Nemours Foundation, Shriners Hospitals for Children, Hanger Inc., Texas Scottish Rite Hospital for Children, Gillette Children's Specialty Healthcare, Paley Orthopedic & Spine Institute LLC, Quantum Rehab a division of Pride Mobility Products Corp., Obi Robot Inc., Gammie HomeCare LLC, Prothotic Laboratories Inc., SSM Health Cardinal Glennon Children's Hospital, and Arthrogryposis Multiplex Congenita Support Inc.

North America was the largest region in the arthrogryposis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in arthrogryposis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the arthrogryposis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Arthrogryposis is a group of congenital conditions marked by multiple joint contractures, leading to stiffness and restricted movement. It occurs when there is reduced fetal movement in the womb, which may be caused by neurological, muscular, or connective tissue disorders.

The main types of arthrogryposis include classic arthrogryposis, distal arthrogryposis, and amyoplasia. Classic arthrogryposis is characterized by multiple joint contractures (stiffness or fixation) present at birth, often associated with muscle weakness and limited mobility. Treatment options include occupational therapy, physical therapy, surgery, imaging diagnostics, and CT scans. The disorder can affect individuals of all ages, from children to the elderly, and treatments are available through various channels, including hospital pharmacies, retail pharmacies, online pharmacies, and other distribution methods.

The arthrogryposis market research report is one of a series of new reports that provides arthrogryposis market statistics, including the arthrogryposis industry global market size, regional shares, competitors with the arthrogryposis market share, detailed arthrogryposis market segments, market trends, and opportunities, and any further data you may need to thrive in the arthrogryposis industry. This arthrogryposis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The arthrogryposis market consists of revenues earned by entities by providing services such as medical diagnosis and consultation, surgical interventions, orthotic services, and pediatric care. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.